AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 165 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $86,000 | -69.2% | 1,871 | -63.0% | 0.01% | -61.5% |
Q2 2021 | $279,000 | +9200.0% | 5,061 | +7933.3% | 0.01% | – |
Q1 2021 | $3,000 | 0.0% | 63 | 0.0% | 0.00% | -100.0% |
Q4 2020 | $3,000 | +50.0% | 63 | 0.0% | 0.00% | – |
Q3 2020 | $2,000 | -75.0% | 63 | -61.8% | 0.00% | -100.0% |
Q2 2020 | $8,000 | +33.3% | 165 | -5.7% | 0.00% | – |
Q1 2020 | $6,000 | -14.3% | 175 | +17.4% | 0.00% | – |
Q4 2019 | $7,000 | +75.0% | 149 | +10.4% | 0.00% | – |
Q3 2019 | $4,000 | +33.3% | 135 | +164.7% | 0.00% | – |
Q2 2019 | $3,000 | 0.0% | 51 | -19.0% | 0.00% | – |
Q2 2017 | $3,000 | -40.0% | 63 | -30.8% | 0.00% | – |
Q1 2017 | $5,000 | -44.4% | 91 | -47.1% | 0.00% | -100.0% |
Q3 2016 | $9,000 | – | 172 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Rock Springs Capital Management LP | 2,710,061 | $67,074,010 | 1.80% |
Bellevue Group AG | 4,013,500 | $99,334,125 | 1.60% |
Eagle Health Investments LP | 267,630 | $6,623,843 | 1.46% |
ARMISTICE CAPITAL, LLC | 3,324,000 | $82,269,000 | 1.26% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 454,000 | $11,236,500 | 0.61% |
Frazier Life Sciences Management, L.P. | 292,002 | $7,227,050 | 0.48% |
ArrowMark Colorado Holdings LLC | 1,573,359 | $38,940,635 | 0.47% |
Deep Track Capital, LP | 422,247 | $10,450,613 | 0.40% |
FARALLON CAPITAL MANAGEMENT LLC | 2,750,829 | $68,083,018 | 0.34% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 24,000 | $593,520 | 0.20% |